Related Experiment Video
Updated: Aug 8, 2026

Use of Shigella flexneri to Study Autophagy-Cytoskeleton Interactions
Published on: September 10, 2014
Interspecies gene transfer in vivo producing an outbreak of multiply resistant shigellosis
R V Tauxe1, T R Cavanagh, M L Cohen
1Division of Bacterial Diseases, Centers for Disease Control, Atlanta, Georgia 30333.
Abstract:
In 1983, a small outbreak of infections caused by a previously unrecognized multiply-drug-resistant Shigella flexneri 3a strain occurred on the Hopi Indian reservation. The index patient, a diabetic woman with recurrent Escherichia coli bacteriuria on prophylactic trimethoprim/sulfamethoxazole (TMP/SMZ) therapy, was hospitalized with concurrent E. coli urinary tract infection and shigellosis. Both E. coli isolated from her urine and S. flexneri isolated from her stool were resistant to ampicillin, carbenicillin, streptomycin, sulfisoxazole, tetracycline, and TMP/SMZ. Both isolates contained a 35-MDa plasmid transferrable to recipient E. coli, and transconjugates acquiring the plasmid from either donor strain also acquired resistance to the same agents. The number and size of fragments generated by plasmid digestion with DNA restriction endonuclease ClaI were similar. A review of clinical microbiology records showed that an E. coli strain isolated from the patient 3 w before the onset of shigellosis had identical antimicrobial resistance to the E. coli and Shigella isolated during the outbreak. These studies indicate that the index patient receiving prophylactic TMP/SMZ was the likely source of the R-plasmid for the outbreak strain of Shigella.
Insights
A diabetic patient on trimethoprim/sulfamethoxazole (TMP/SMZ) therapy likely spread a multiply-drug-resistant Shigella flexneri strain. This strain acquired its resistance plasmid from an Escherichia coli strain also present in the patient.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- An outbreak of multiply-drug-resistant Shigella flexneri 3a occurred on the Hopi Indian reservation in 1983.
- The index patient had a concurrent Escherichia coli urinary tract infection and shigellosis.
Observation:
- Both E. coli and S. flexneri isolates from the index patient exhibited resistance to multiple antibiotics.
- A transferable 35-MDa plasmid was identified in both E. coli and S. flexneri isolates.
- An E. coli strain isolated from the patient weeks prior showed identical antimicrobial resistance patterns.
Findings:
- The E. coli and S. flexneri isolates shared a common 35-MDa plasmid conferring multiple drug resistance.
- The plasmid was transferable to recipient E. coli strains.
- The index patient's prior E. coli infection possessed the same resistance plasmid.
Implications:
- The index patient, undergoing prophylactic trimethoprim/sulfamethoxazole (TMP/SMZ) therapy, was identified as the probable source of the R-plasmid for the outbreak strain.
- This highlights the potential for antimicrobial resistance plasmids to transfer between different bacterial species in a single host.
- Understanding plasmid-mediated resistance is crucial for controlling infectious disease outbreaks.
Related Concept Videos
Viral Recombination
Genome Size and the Evolution of New Genes
Types of Genetic Transfer Between Organisms
Horizontal Gene Transfer
Transduction
Bacterial Gastroenteritis

